Provided by Tiger Trade Technology Pte. Ltd.

Oppenheimer

93.86
-2.7500-2.85%
Post-market: 93.860.00000.00%17:36 EDT
Volume:53.49K
Turnover:5.05M
Market Cap:1.00B
PE:10.84
High:96.53
Open:96.53
Low:93.29
Close:96.61
52wk High:118.77
52wk Low:61.26
Shares:10.71M
Float Shares:5.93M
Volume Ratio:0.73
T/O Rate:0.90%
Dividend:0.74
Dividend Rate:0.79%
EPS(TTM):8.66
EPS(LYR):13.04
ROE:10.53%
ROA:2.62%
PB:1.06
PE(LYR):7.20

Loading ...

Intuit price target lowered to $406 from $558 at Oppenheimer

TIPRANKS
·
May 21

Vertiv price target raised to $353 from $330 at Oppenheimer

TIPRANKS
·
May 21

Oppenheimer Initiates JBT Marel at Outperform With $175 Price Target

MT Newswires Live
·
May 21

Oppenheimer Keeps Their Buy Rating on OSI Systems (OSIS)

TIPRANKS
·
May 21

LP Building Solutions management to meet with Oppenheimer

TIPRANKS
·
May 21

Unusual Machines management to meet with Oppenheimer

TIPRANKS
·
May 21

Zscaler Likely to See Balanced Fiscal Q3 Results, Oppenheimer Says

MT Newswires Live
·
May 20

Sweetgreen Supported by Wraps Launch, Operational Improvements and Easier Comparisons, Oppenheimer Says

MT Newswires Live
·
May 20

OSI Systems Positioned for Earnings Growth After Solid Q3, Oppenheimer Says

MT Newswires Live
·
May 20

Rubrik Benefits From Rebounding Backup, Recovery Demand, Oppenheimer Says

MT Newswires Live
·
May 20

Dutch Bros' Competitive Fears are Overblown, Oppenheimer Says

MT Newswires Live
·
May 20

Oppenheimer Adjusts Price Target on Sweetgreen to $10 From $9, Maintains Outperform Rating

MT Newswires Live
·
May 20

Oppenheimer Adjusts Protara Therapeutics PT to $28 From $25, Maintains Outperform Rating

MT Newswires Live
·
May 20

Protara Therapeutics (TARA) Receives a Buy from Oppenheimer

TIPRANKS
·
May 20

Oppenheimer Remains a Buy on Nutanix (NTNX)

TIPRANKS
·
May 20

Protara Therapeutics price target raised to $28 from $25 at Oppenheimer

TIPRANKS
·
May 20

Rubrik Raised to Outperform From Perform by Oppenheimer

Dow Jones
·
May 20

Oppenheimer Upgrades Rubrik to Outperform From Market Perform, Price Target is $85

MT Newswires Live
·
May 20

Oppenheimer upgrades Rubrik to Outperform on sector, product strength

TIPRANKS
·
May 20

Okta Likely to Deliver Modest Fiscal Q1 Revenue Upside, Oppenheimer Says

MT Newswires Live
·
May 19